(NP (NP (NN Introduction)) (: :) (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (VBG challenging)) (PP (IN at) (NP (NN baseline))) (S (VP (TO to) (VP (VB predict) (SBAR (WHADVP (WRB when) (CC and) (WHNP (WDT which))) (S (NP (NP (NNS individuals)) (SBAR (WHNP (WP who)) (S (VP (VBP meet) (NP (NP (NNS criteria)) (PP (IN for) (NP (NP (JJ mild) (JJ cognitive) (NN impairment)) (PRN (-LRB- -LRB-) (NP (NNP MCI)) (-RRB- -RRB-))))))))) (VP (MD will) (ADVP (RB ultimately)) (VP (VB progress) (PP (TO to) (NP (NP (NNP Alzheimer) (POS 's)) (NN disease) (PRN (-LRB- -LRB-) (NP (NNP AD)) (-RRB- -RRB-)) (NN dementia)))))))))))) (. .))
(NP (NP (NNS Methods)) (: :) (S (NP (DT A) (JJ deep) (NN learning) (NN method)) (VP (VBZ is) (VP (VBN developed) (CC and) (VBN validated) (PP (VBN based) (PP (IN on) (NP (NP (NNP MRI) (NNS scans)) (PP (IN of) (NP (NP (CD 2146) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 803)) (PP (IN for) (NP (NN training)))) (CC and) (NP (NP (CD 1343)) (PP (IN for) (NP (NN validation))))) (-RRB- -RRB-))))))) (S (VP (TO to) (VP (VB predict) (NP (NP (NP (NNP MCI) (NNS subjects) (POS ›)) (NN progression)) (PP (TO to) (NP (NNP AD) (NN dementia)))) (PP (IN in) (NP (DT a) (JJ time-to-event) (NN analysis) (NN setting))))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (DT The) (JJ deep) (NN learning) (JJ time-to-event) (NN model)) (VP (VBD predicted) (NP (NP (NP (JJ individual) (NNS subjects) (POS ›)) (NN progression)) (PP (TO to) (NP (NNP AD) (NN dementia)))) (PP (IN with) (NP (NP (NP (DT a) (NN concordance) (NN index)) (PRN (-LRB- -LRB-) (NP (NNP C-index)) (-RRB- -RRB-)) (PP (IN of) (NP (CD 0.762))) (PP (IN on) (NP (NP (CD 439) (NNP ADNI) (VBG testing) (NNP MCI) (NNS subjects)) (PP (IN with) (NP (NP (JJ follow-up) (NN duration)) (PP (IN from) (NP (QP (CD 6) (TO to)) (NP (CD 78) (NNS months)))))))) (PRN (-LRB- -LRB-) (NP (NP (NNS quartiles)) (: :) (NN -LSB-) (CD 24) (, ,) (CD 42) (, ,) (CD 54) (NN -RSB-)) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (NN C-index)) (PP (IN of) (NP (CD 0.781))) (PP (IN on) (NP (NP (NP (CD 40) (NNP AIBL) (VBG testing) (NNP MCI) (NNS subjects)) (PP (IN with) (NP (NP (JJ follow-up) (NN duration)) (PP (IN from) (NP (JJ 18-54) (NNS months)))))) (PRN (-LRB- -LRB-) (NP (NP (NNS quartiles)) (: :) (NN -LSB-) (CD 18) (, ,) (CD 36,54) (NN -RSB-)) (-RRB- -RRB-))))))))) (. .))
(S (NP (DT The) (JJ predicted) (NN progression) (NN risk)) (ADVP (RB also)) (VP (VBD clustered) (NP (JJ individual) (NNS subjects)) (PP (IN into) (NP (NP (NNS subgroups)) (PP (IN with) (NP (NP (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (NP (PRP$ their) (NN progression) (NN time)) (PP (TO to) (NP (NNP AD) (NN dementia)))) (PRN (-LRB- -LRB-) (NP (JJ p) (NNP <) (CD 0.0002)) (-RRB- -RRB-))))))))) (. .))
(S (NP (NP (NP (VBN Improved) (NN performance)) (PP (IN for) (S (VP (VBG predicting) (NP (NP (NN progression)) (PP (TO to) (NP (NNP AD) (NN dementia)))))))) (PRN (-LRB- -LRB-) (NP (NNP C-index=0.864)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN obtained) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (ADJP (JJ deep) (NN learning) (VBN based)) (NN progression) (NN risk)) (VP (VBD was) (VP (VBN combined) (PP (IN with) (NP (JJ baseline) (JJ clinical) (NNS measures))))))))) (. .))
(NP (NP (NN Conclusion)) (: :) (S (NP (PRP$ Our) (NN method)) (VP (VBZ provides) (NP (NP (DT a) (ADJP (NN cost) (JJ effective) (CC and) (JJ accurate)) (NNS means)) (UCP (PP (IN for) (NP (NN prognosis))) (CC and) (ADVP (RB potentially)) (VP (TO to) (VP (VB facilitate) (NP (NP (NN enrollment)) (PP (IN in) (NP (NP (JJ clinical) (NNS trials)) (PP (IN with) (NP (NP (NNS individuals)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB progress) (PP (IN within) (NP (DT a) (JJ specific) (JJ temporal) (NN period)))))))))))))))))) (. .))
